How did we get here? Until now, vaccines for all children under age 12 had been available under emergency use authorization ...

A Qatar-based study involving 121,700 patients has underscored the importance of the post-vaccination monitoring to optimise ...

Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...

Amid growing concerns over the safety of COVID-19 vaccines, a significant lawsuit against prominent figures in the pharmaceutical industry and public health has taken a dramatic turn. Three new ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

Ursula von der Leyen, the EU’s most powerful official, coasted to victory after a no-confidence vote on Thursday. Some of her ...

Cypriot members of the European parliament were evenly split over a no-confidence vote in European Commission President Ursula von der Leyen, with two voting in favour, two voting against, and two not ...

BRUSSELS -- European Commission President Ursula von der Leyen comfortably survived a vote of no confidence on Thursday as an ...